Is KIN or YUM a better dividend investment in 2026?

KIN currently yields 21.62% with a 5% 5-year dividend growth rate. YUM yields 1.86% with 5% growth. The better choice depends on your goal: KIN offers higher current income.

What is the dividend yield difference between KIN and YUM?

KIN has a forward dividend yield of 21.62% ($2.00/share annually). YUM yields 1.86% ($2.88/share annually). The yield gap is 19.76 percentage points.

Home › Compare › KIN vs YUM

KIN vs YUM: Dividend Comparison 2026

KIN yields 21.62% · YUM yields 1.86%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 YUM wins by $27.3K in total portfolio value· pulled ahead in Year 10

INVESTMENT

TIME HORIZON10 years

KIN

● Live price

21.62%

Share price

$9.25

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$80.6K

Annual income

$7,983.46

Full KIN calculator →

YUM

● Live price

1.86%

Share price

$154.59

Annual div

$2.88

5Y div CAGR

51.4%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$107.9K

Annual income

$40,443.52

Full YUM calculator →

Portfolio growth — KIN vs YUM

📍 YUM pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	KIN	YUM
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, KIN + YUM cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

KIN pays

YUM pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KIN

Annual income on $10K today (after 15% tax)

$1,837.84/yr

After 10yr DRIP, annual income (after tax)

$6,785.94/yr

YUM

Annual income on $10K today (after 15% tax)

$158.35/yr

After 10yr DRIP, annual income (after tax)

$34,376.99/yr

At 15% tax rate, YUM beats the other by $27,591.05/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KIN + YUM for your $10,000?

KIN: 50%YUM: 50%

100% YUM50/50100% KIN

Portfolio after 10yr

$94.3K

Annual income

$24,213.49/yr

Blended yield

25.68%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on YUM right now

KIN

No analyst data

YUM

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$173.15

+12.0% upside vs current

Range: $158.00 — $190.00

Altman Z

2.6

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KIN buys

YUM buys

No recent congressional trades found for KIN or YUM in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricKINYUM

Forward yield	21.62% ✓	1.86%
Annual dividend / share	$2.00	$2.88 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	51.4% ✓
Portfolio after 10y	$80.6K	$107.9K ✓
Annual income after 10y	$7,983.46	$40,443.52 ✓
Total dividends collected	$47.7K	$81.2K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Discretionary

Year-by-year: KIN vs YUM ($10,000, DRIP)

Year	KIN Portfolio	KIN Income/yr	YUM Portfolio	YUM Income/yr	Gap
1	$12,862	$2,162.16	$10,982	$282.06	+$1.9K → KIN
2	$16,362	$2,599.07	$12,189	$438.29	+$4.2K → KIN
3	$20,597	$3,089.91	$13,731	$688.32	+$6.9K → KIN
4	$25,674	$3,635.27	$15,789	$1,097.12	+$9.9K → KIN
5	$31,706	$4,234.91	$18,679	$1,785.08	+$13.0K → KIN
6	$38,813	$4,887.76	$22,975	$2,988.18	+$15.8K → KIN
7	$47,122	$5,591.96	$29,784	$5,200.49	+$17.3K → KIN
8	$56,765	$6,344.91	$41,408	$9,539.16	+$15.4K → KIN
9	$67,882	$7,143.35	$63,071	$18,765.27	+$4.8K → KIN
10← crossover	$80,618	$7,983.46	$107,930	$40,443.52	$27.3K → YUM

KIN vs YUM: Complete Analysis 2026

KIN — Stock

Kindred Biosciences, Inc., a biopharmaceutical company, is developing biologics that focus on the lives of pets. The company has a pipeline of novel biologics in development across various therapeutic classes and intellectual property portfolio. Its programs under development include interleukin-31 and interleukin-4R for canine atopic dermatitis; KIND-030 for parvovirus in dogs; KIND-510a for the control of non-regenerative anemia in cats; anti-TNF antibody for inflammatory bowel disease in dogs; and other biologics candidates. The company was founded in 2012 and is headquartered in Burlingame, California.

Full KIN Calculator →

YUM — Consumer Discretionary

YUM! Brands, Inc., together with its subsidiaries, develops, operates, and franchises quick service restaurants worldwide. It operates through four segments: the KFC Division, the Taco Bell Division, the Pizza Hut Division, and the Habit Burger Grill Division. The company operates restaurants under the KFC, Pizza Hut, Taco Bell, and The Habit Burger Grill brands, which specialize in chicken, pizza, made-to-order chargrilled burgers, sandwiches, Mexican-style food categories, and other food products. As of December 31, 2021, it had 26,934 KFC units; 18,381 Pizza Hut units; 7,791 Taco Bell units; and 318 The Habit Burger Grill units in approximately 157 countries and territories. The company was formerly known as TRICON Global Restaurants, Inc. and changed its name to YUM! Brands, Inc. in May 2002. YUM! Brands, Inc. was incorporated in 1997 and is headquartered in Louisville, Kentucky.

Full YUM Calculator →

📬

Get this KIN vs YUM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KIN vs SCHD KIN vs JEPI KIN vs O KIN vs KO KIN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.